Opiant Pharmaceuticals Awarded Grant of Approximately $7.4 Million from the National Institutes of Health for Development of OPNT003 Pharmaceutical Investing
Solid Biosciences Provides Update On SGT-001 Clinical Development Program For Duchenne Muscular Dystrophy Biotech Investing
Akcea and Ionis Complete Licensing Transaction to Commercialize Inotersen for hATTR Pharmaceutical Investing
VBI Vaccines Announces Positive DSMB Review in Phase 1/2a Study of VBI-1901 in Recurrent Glioblastoma (GBM) Patients Pharmaceutical Investing
Anavex Life Sciences to Initiate Phase 2 Study of ANAVEX®2-73 in Parkinson’s Disease Dementia Pharmaceutical Investing
Advent International enters into exclusive negotiations to acquire Zentiva, Sanofi’s European generics business Pharmaceutical Investing
